New tech can cut EPO, insulin prices to one-eighth
Pharmaceutical companies will be able to produce life-saving proteins such as insulin, erythropoietin and interferon at one-eighth their current cost by using a process involving VFF2 technology.
More: continued here
Permalink for New tech can cut EPO, insulin prices to one-eighth